Organon (OGN) Tops Q4 EPS by 9c, provides guidance

Organon (NYSE: OGN) reported Q4 EPS of $0.88, $0.09 better than the analyst estimate of $0.79. Revenue for the quarter came in at $1.6 billion versus the consensus estimate of $1.56 billion.

GUIDANCE:

Organon sees Q1 2024 revenue of $6.2-6.5 billion, versus the consensus of $6.396 billion.

For earnings history and earnings-related data on Organon (OGN) click here.

You May Also Be Interested In

• Fox upgraded to overweight as Roku deal, ad strength lift outlook
• Stardust Power (SDST) Tops Q2 EPS by 1c
• Instil Bio Inc. (TIL) Misses Q2 EPS by 21c